Allergic bronchopulmonary aspergillosis
Abstract:
Allergic bronchopulmonary aspergillosis (ABPA) is not a common condition, even though asthma due to sensitization to Aspergillus antigen is very common in many countries because of the ubiquitous distribution of the fungus itself. During the course of 14 years, the Mycology Department of the V. P. Chest Institute, Delhi, has confirmed the diagnosis of ABPA in 46 patients. The present study is based on the follow-up of 17 patients for understanding the evolution of the disease. All of them had Aspergillus fumigatus (AF) in the sputum with positive type I and type III skin reaction to AF antigen. 7 patients were treated for 10 days with oral administration of Hamycin, an antibiotic isolated from one of the streptomycete species. Immediate results were very good, with marked alleviation of subjective symptoms and absence of fungi in the sputum. The drug deserves further trial.
Insights
Allergic bronchopulmonary aspergillosis (ABPA) is rare, but this study found the antibiotic Hamycin effective in treating 7 patients. Hamycin showed good initial results, alleviating symptoms and clearing Aspergillus fumigatus from sputum.
Area of Science:
- Medical Mycology
- Pulmonology
- Infectious Diseases
Background:
- Allergic bronchopulmonary aspergillosis (ABPA) is an uncommon condition.
- Asthma sensitization to Aspergillus antigen is prevalent globally due to the fungus's widespread presence.
- The Mycology Department diagnosed 46 ABPA cases over 14 years.
Purpose of the Study:
- To understand the disease evolution of Allergic bronchopulmonary aspergillosis.
- To evaluate the efficacy of Hamycin in treating ABPA patients.
Main Methods:
- Follow-up study of 17 Allergic bronchopulmonary aspergillosis patients.
- Diagnosis confirmed by Aspergillus fumigatus in sputum and positive skin reactions.
- Treatment group of 7 patients received oral Hamycin for 10 days.
Main Results:
- Immediate positive outcomes observed in treated patients.
- Marked alleviation of subjective symptoms reported.
- Absence of Aspergillus fumigatus in sputum post-treatment.
Conclusions:
- Hamycin demonstrates promising immediate results for Allergic bronchopulmonary aspergillosis treatment.
- The antibiotic Hamycin warrants further clinical trials for ABPA management.
Related Concept Videos
Fungal Phylum Ascomycota
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation


